Q2 2024 Holdings
Filed 2024-08-14 | 33 holdings | $522.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Urogen Pharma LTD(URGN) | COM | M96088105 | $48.8M | 2,906,259 | 9.3% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $36.5M | 1,004,291 | 7.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $32.7M | 2,472,188 | 6.3% |
| Merus N V | COM | N5749R100 | $31.0M | 523,288 | 5.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $28.3M | 2,636,864 | 5.4% |
| Arcellx Inc(ACLX) | COMMON STOCK | 03940C100 | $27.2M | 492,000 | 5.2% |
| Dynavax Technologies Corp(DVAX) | COM NEW | 268158201 | $26.7M | 2,374,000 | 5.1% |
| Evolus Inc(EOLS) | COM | 30052C107 | $26.6M | 2,451,772 | 5.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $25.7M | 474,202 | 4.9% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $19.6M | 757,929 | 3.8% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $16.8M | 250,000 | 3.2% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $16.2M | 4,642,241 | 3.1% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $15.8M | 1,338,568 | 3.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $15.7M | 330,000 | 3.0% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $14.9M | 7,419,355 | 2.8% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $14.8M | 1,495,500 | 2.8% |
| Optinose Inc | COM | 68404V100 | $14.3M | 13,727,097 | 2.7% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $12.9M | 5,791,594 | 2.5% |
| Voyager Therapeutics Inc(VYGR) | COM | 92915B106 | $12.7M | 1,601,527 | 2.4% |
| Outlook Therapeutics Inc(OTLK) | COM | 69012T305 | $12.6M | 1,701,510 | 2.4% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $12.0M | 3,441,667 | 2.3% |
| Jasper Therapeutics Inc(JSPR) | COM NEW | 471871202 | $9.1M | 402,015 | 1.7% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $8.6M | 796,880 | 1.7% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $7.8M | 1,149,406 | 1.5% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $6.5M | 500,000 | 1.2% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $5.5M | 940,831 | 1.1% |
| Vistagen Therapeutics Inc(VTGN) | COM | 92840H400 | $5.3M | 1,529,338 | 1.0% |
| Helix Acquisition Corp II | CL A ORD SHS | G4444H101 | $5.1M | 500,000 | 1.0% |
| Puma Biotechnology Inc(PBYI) | COM | 74587V107 | $4.8M | 1,486,544 | 0.9% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $3.7M | 499,152 | 0.7% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $3.2M | 134,612 | 0.6% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $626.5K | 25,000 | 0.1% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $50.4K | 30,000 | 0.0% |